Consolidated Portfolio Review Corp Has $377,000 Stake in MetLife, Inc. (NYSE:MET)

Consolidated Portfolio Review Corp boosted its position in MetLife, Inc. (NYSE:MET) by 10.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,601 shares of the financial services provider’s stock after purchasing an additional 427 shares during the quarter. Consolidated Portfolio Review Corp’s holdings in MetLife were worth $377,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of MetLife by 1.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock valued at $375,179,000 after acquiring an additional 68,579 shares during the period. Nordea Investment Management AB boosted its holdings in MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after purchasing an additional 608,224 shares during the period. Swedbank AB grew its position in shares of MetLife by 76.0% during the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock worth $283,862,000 after purchasing an additional 1,496,645 shares in the last quarter. Jennison Associates LLC increased its holdings in shares of MetLife by 3.6% during the fourth quarter. Jennison Associates LLC now owns 3,274,258 shares of the financial services provider’s stock worth $268,096,000 after purchasing an additional 114,166 shares during the period. Finally, Stifel Financial Corp boosted its stake in shares of MetLife by 5.0% in the third quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider’s stock valued at $184,744,000 after buying an additional 105,762 shares during the period. 94.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. TD Cowen raised their price objective on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Barclays reduced their price objective on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a research note on Friday. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Finally, BMO Capital Markets started coverage on shares of MetLife in a research report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, MetLife has an average rating of “Moderate Buy” and an average price target of $91.08.

MetLife Stock Up 0.4 %

Shares of NYSE:MET opened at $83.99 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 52-week low of $66.18 and a 52-week high of $89.05. The company has a market capitalization of $58.16 billion, a PE ratio of 16.93, a price-to-earnings-growth ratio of 0.66 and a beta of 1.07. The company has a fifty day moving average of $83.80 and a 200-day moving average of $80.73.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 5.27% and a return on equity of 20.01%. On average, equities analysts predict that MetLife, Inc. will post 8.18 EPS for the current fiscal year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.60%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s payout ratio is 36.52%.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.